(Press-News.org) For the first time, researchers at the University of California, San Diego School of Medicine have isolated and characterized the progenitor cells that eventually give rise to malignant hepatocellular carcinoma (HCC) tumors – the most common form of liver cancer. The researchers found ways to identify and isolate the HCC progenitor cells (HcPC) long before actual tumors were apparent.
Writing in the October 10, 2013 issue of the journal Cell, principal investigator Michael Karin, PhD, Distinguished Professor of Pharmacology and Pathology, and colleagues report that HcPC take form within dysplastic or abnormal lesions often found in damaged or cirrhotic livers. The liver damage can be due to viral infections like hepatitis or from chronic alcohol abuse.
"It was never established whether dysplastic lesions are just a regenerative (healing) response of the liver triggered by tissue damage or are actually pre-malignant lesions that harbor tumor progenitor cells," said study co-author Debanjan Dhar, PhD, a postdoctoral researcher in Karin's lab. "Here we show that HcPC are likely derived from dysplastic lesions, can progress to malignant tumors and further demonstrate that the malignant progression of HcPC to full-blown liver cancer depends upon the microenvironment that surrounds them."
The researchers were able to characterize HcPC based on several biomarkers that distinguish them from normal cells. They also identified cellular signaling pathways activated in HcPC that are critical "to their malignant potential," said Dhar.
The findings may have profound implications for treating HCC which, while relatively rare in the United States compared to other types of cancer, is difficult to diagnose and treat, with poor prognoses for patients. HCC is usually fatal within three to six months of diagnosis, according to National Institutes of Health data. An estimated 30,000 new cases of liver cancer are diagnosed annually in the U.S., predominantly among men. More than 21,600 Americans die from liver cancer each year, a rate that has been rising slowly for several decades. In other parts of the world, HCC is a major cause of cancer-related deaths.
Most cancers are best detected and treated at the earliest possible stage. HCC is problematic because it develops slowly and frequently displays no symptoms. By the time it is detected, said Dhar, it is usually at an advanced stage with no effective therapy.
"Our findings can be translated into both early detection and therapeutic intervention," he said. "Better understanding of HcPC cellular networks will provide us with new and effective therapeutic targets."
For example, the researchers were able to detect "potential" malignant lesions in needle biopsies of a subset of patients infected with the hepatitis C virus, but who hadn't yet developed HCC. Hepatitis C is a major risk factor for HCC development.
Dhar said identifying premalignant lesions in high-risk patients based on HcPC markers would allow for earlier detection and therapeutic interventions. "Furthermore, in future, therapies can be developed to specifically eliminate the HcPC even before a tumor has developed."
INFORMATION:
Co-authors include Guobin He, Joan Font-Burgada, Yuhong Jiang and Shabnam Shalapour, Laboratory of Gene Regulation and Signal Transduction, Departments of Pharmacology and Pathology, UCSD; Hayato Nakagawa, Laboratory of Gene Regulation and Signal Transduction, Departments of Pharmacology and Pathology, UCSD and Department of Gastroenterology, University of Tokyo; Hisanobu Ogata, Laboratory of Gene Regulation and Signal Transduction, Departments of Pharmacology and Pathology, UCSD and Department of Medicine and Clinical Science, Kyushu University, Japan; Ekihiro Seki, Department of Medicine, UCSD; Shawn E. Yost, Bioinformatics Graduate Program and Rady Children's Hospital-San Diego and Department of Pediatrics, UCSD; Kristen Jepsen, Rady Children's Hospital-San Diego and Department of Pediatrics, UCSD; Kelly A. Frazer, Rady Children's Hospital-San Diego and Department of Pediatrics, UCSD, UC San Diego Moores Cancer Center, Clinical and Translational Research Institute, UCSD and Institute for Genomic Medicine, UCSD; Olivier Harismendy, Rady Children's Hospital-San Diego and Department of Pediatrics, UCSD, UC San Diego Moores Cancer Center, Clinical and Translational Research Institute, UCSD; Maria Hatziapostolou and Dimitrios Iliopoulos, Center for Systems Biomedicine, Geffen School of Medicine, UCLA; Atsushi Suetsugu and Robert M. Hoffman, Department of Surgery, UCSD and Anticancer, Inc., San Diego; and Ryosuke Tateishi and Kazuhiko Koike, Department of Gastroenterology, University of Tokyo.
Funding support for this research came, in part, from the Superfund Basic Research Program, the National Institutes of Health (CA118165 and CA155120), Wellcome Trust, American Diabetes Association, the Center for Translational Science, the National Center for Research Resources IMAT program, postdoctoral research fellowships from the Damon Runyon Cancer Research Foundation, the American Liver Foundation, Daiichi Sankyo Foundation of Life Science, the California Institute for Regenerative Medicine Stem Cell Training Grant II, Kanzawa Medical Research Foundation, the German Research Foundation and a Young Investigator Award from the National Childhood Cancer Foundation "CureSearch."
Researchers identify liver cancer progenitor cells before tumors become visible
2013-10-10
ELSE PRESS RELEASES FROM THIS DATE:
Stomach cells naturally revert to stem cells
2013-10-10
New research has shown that the stomach naturally produces more stem cells than previously realized, likely for repair of injuries from infections, digestive fluids and the foods we eat.
Stem cells can make multiple kinds of specialized cells, and scientists have been working for years to use that ability to repair injuries throughout the body. But causing specialized adult cells to revert to stem cells and work on repairs has been challenging.
Scientists from Washington University School of Medicine in St. Louis and Utrecht Medical Center in the Netherlands report ...
Eat more, weigh less: Worm study provides clues to better fat-loss therapies for humans
2013-10-10
LA JOLLA, CA—October 10, 2013 —Scientists at The Scripps Research Institute (TSRI) have discovered key details of a brain-to-body signaling circuit that enables roundworms to lose weight independently of food intake. The weight-loss circuit is activated by combined signals from the worm versions of the neurotransmitters serotonin and adrenaline, and there are reasons to suspect that it exists in a similar form in humans and other mammals.
"Boosting serotonin signaling has been seen as a viable strategy for weight loss in people, but our results hint that boosting serotonin ...
Stem cell breakthrough could set up future transplant therapies
2013-10-10
A new method for creating stem cells for the human liver and pancreas, which could enable both cell types to be grown in sufficient quantities for clinical use, has been developed by scientists.
Using the technique, researchers have for the first time been able to grow a pure, self-renewing population of stem cells specific to the human foregut, the upper section of the human digestive system.
These so-called "Foregut stem cells" could then be developed further to produce liver or pancreatic cells. The method significantly improves on existing techniques for cultivating ...
Soft shells and strange star clusters
2013-10-10
PGC 6240 is an elliptical galaxy that resembles a pale rose in the sky, with hazy shells of stars encircling a very bright centre. Some of these shells are packed close to the centre of the galaxy, while others are flung further out into space. Several wisps of material have been thrown so far that they appear to be almost detached from the galaxy altogether.
Astronomers have studied PGC 6240 in detail due to this structure, and also because of its surrounding globular clusters — dense, tightly packed groups of gravitationally bound stars that orbit galaxies. Over 150 ...
Direct 'writing' of artificial cell membranes on graphene
2013-10-10
Writing in Nature Communications, researchers at The University of Manchester led by Dr Aravind Vijayaraghavan, and Dr Michael Hirtz at the Karlsruhe Institute of Technology (KIT), have demonstrated that membranes can be directly 'written' on to a graphene surface using a technique known as Lipid Dip-Pen Nanolithography (L-DPN).
The human body contains 100 trillion cells, each of which is enveloped in a cell membrane which is essentially a phospholipid bi-layer membrane. These cell membranes have a plethora of proteins, ion channels and other molecules embedded in them, ...
Look out above! Experiment explores innate visual behavior in mice
2013-10-10
When you're a tiny mouse in the wild, spotting aerial predators—like hawks and owls—is essential to your survival. But once you see an owl, how is this visual cue processed into a behavior that helps you to avoid an attack? Using an experimental video technique, researchers at the California Institute of Technology (Caltech) have now developed a simple new stimulus with which they can spur the mouse's escape plans. This new stimulus allows the researchers to narrow down cell types in the retina that could aid in the detection of aerial predators.
"The mouse has recently ...
Super-enhancers seen as 'Rosetta Stone' for dialog between genes and disease
2013-10-10
CAMBRIDGE, Mass. (October 10, 2013) – Having recently discovered a set of powerful gene regulators that control cell identity in a few mouse and human cell types, Whitehead Institute scientists are now showing that these regulators—which they named "super-enhancers"—act across a vast array of human cell types and are enriched in mutated regions of the genome that are closely associated with a broad spectrum of diseases.
The findings, published online today by the journal Cell, suggest that these super-enhancers, first described in Cell several months ago by Whitehead ...
Genes predispose some people to focus on the negative
2013-10-10
A new study by a University of British Columbia researcher finds that some people are genetically predisposed to see the world darkly.
The study, published in Psychological Science, finds that a previously known gene variant can cause individuals to perceive emotional events—especially negative ones – more vividly than others.
"This is the first study to find that this genetic variation can significantly affect how people see and experience the world," says Prof. Rebecca Todd of UBC's Dept. of Psychology. "The findings suggest people experience emotional aspects of ...
Scientists find potential new targets for anti-inflammatory therapies
2013-10-10
LA JOLLA, CA -- October 9, 2013 -- A team led by scientists at The Scripps Research Institute (TSRI) has identified key signaling proteins in the inflammation process that contribute to the development of inflammatory diseases such as rheumatoid arthritis, psoriasis, sepsis and inflammatory bowel diseases. The finding highlights possible new ways of treating these inflammation disorders, which sicken or kill millions of people around the world each year.
"We hope our approach will lead to the development of drugs that augment current anti-inflammatory strategies," said ...
Gene movements observed in vivo
2013-10-10
This new method will be a great step forwards to understanding the resulting processes that control gene regulation.
These results were published on October 6, 2013 on the website of the review Nature Structural & Molecular Biology.
In the cell nucleus, DNA is highly dynamic and changes its spatial configuration, in the same way as during the process of cell division. We already know that the spatial configuration of DNA determines whether the genes are active or inactive, in other words whether they are capable of expression. In this study, the researchers attempted ...